Deranda B. Lester
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Deranda B. Lester has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Charles D. Blaha
Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, 55905, USA; Neural Engineering and Precision Surgery Laboratories, Mayo Clinic, Rochester, MN, 55905, USA
7 shared publications - Helen J. K. Sable
University of Memphis
4 shared publications Hunter G. Nolen
Department of Psychology, The University of Memphis
4 shared publicationsAnthony D. Miller
Department of Psychology, The University of Memphis, Memphis, Tennessee 38152
3 shared publicationsMegan A. McWain
Department of Psychology, The University of Memphis
3 shared publicationsTiffany D. Rogers
Department of Psychology, University of Memphis, Memphis, USA
3 shared publications
Latest Publications
- 24 April 2026
- Published by Taylor & Francis in Social Neuroscience
- p. 1-12
The relationship between social reward behavior and mesolimbic dopamine release
Social aversion and withdrawal are symptoms exhibited in a variety of psychiatric disorders, including depression, substance use disorder (SUD), schizophrenia, and autism (American Psychiatric Asso...
- 24 April 2026
- Published by Taylor & Francis in Social Neuroscience
- p. 1-12
The relationship between social reward behavior and mesolimbic dopamine release
Social aversion and withdrawal are symptoms exhibited in a variety of psychiatric disorders, including depression, substance use disorder (SUD), schizophrenia, and autism (American Psychiatric Asso...
- Open Access
The Relationship between Social Reward Behavior and Mesolimbic Dopamine Release
Deficits in social behavior, such as reduced motivation and social avoidance, are key symptoms in several psychiatric disorders. Distinct modes of reward, such as drug and social, may rely on different dopamine release patterns in the mesolimbic pathway. We investigated the relationship between social reward behaviors and dopamine release elicited by phasic and tonic stimulation patterns in C57BL/6J mice. Social conditioned place preference was used to assess motivation for social interaction, and in vivo fixed potential amperometry was used to measure nucleus accumbens dopamine release before and after cocaine (10 mg/kg, ip). Additional measures included the frequency and duration of social interactions during conditioning sessions, with the first and last session representing novel and familiar social interactions respectively. No relationship was found between baseline (pre-cocaine) dopamine and social place preference in either sex. However, in males, social place preference negatively correlated with cocaine-induced phasic dopamine release, indicating that increased social motivation was associated with a reduced phasic dopaminergic response to cocaine. In contrast, greater novel interaction was associated with increased baseline dopamine elicited by tonic stimulations. These relationships were not observed in females. Overall, these findings suggest distinct, sex-dependent roles for phasic and tonic dopamine release in mediating social reward.
Open AccessThe Relationship between Social Reward Behavior and Mesolimbic Dopamine Release
Deficits in social behavior, such as reduced motivation and social avoidance, are key symptoms in several psychiatric disorders. Distinct modes of reward, such as drug and social, may rely on different dopamine release patterns in the mesolimbic pathway. We investigated the relationship between social reward behaviors and dopamine release elicited by phasic and tonic stimulation patterns in C57BL/6J mice. Social conditioned place preference was used to assess motivation for social interaction, and in vivo fixed potential amperometry was used to measure nucleus accumbens dopamine release before and after cocaine (10 mg/kg, ip). Additional measures included the frequency and duration of social interactions during conditioning sessions, with the first and last session representing novel and familiar social interactions respectively. No relationship was found between baseline (pre-cocaine) dopamine and social place preference in either sex. However, in males, social place preference negatively correlated with cocaine-induced phasic dopamine release, indicating that increased social motivation was associated with a reduced phasic dopaminergic response to cocaine. In contrast, greater novel interaction was associated with increased baseline dopamine elicited by tonic stimulations. These relationships were not observed in females. Overall, these findings suggest distinct, sex-dependent roles for phasic and tonic dopamine release in mediating social reward.
- 7 February 2025
- Published by Elsevier in Neuroscience Letters
- Vol. 850, 138153
Effects of kratom alkaloids on mesolimbic dopamine release
- 7 February 2025
- Published by Elsevier in Neuroscience Letters
- Vol. 850, 138153
Effects of kratom alkaloids on mesolimbic dopamine release
- 4 January 2025
- Published by Elsevier in Neuroscience
- Vol. 567, 150-162
Phasic dopamine release in two different rat models of attention-deficit/hyperactivity disorder: Spontaneously hypertensive rats (SHR) versus Lphn3 knockout rats
- 4 January 2025
- Published by Elsevier in Neuroscience
- Vol. 567, 150-162
Phasic dopamine release in two different rat models of attention-deficit/hyperactivity disorder: Spontaneously hypertensive rats (SHR) versus Lphn3 knockout rats
- 1 April 2024
- Published by American Psychological Association (APA) in Behavioral Neuroscience
- Vol. 138 (2) , 108-124
Indirect and direct cannabinoid agonists differentially affect mesolimbic dopamine release and related behaviors.
The cannabinoid system is being researched as a potential pharmaceutical target for a multitude of disorders. The present study examined the effect of indirect and direct cannabinoid agonists on mesolimbic dopamine release and related behaviors in C57BL/6J (B6) mice. The indirect cannabinoid agonist N-arachidonoyl serotonin (AA-5-HT) indirectly agonizes the cannabinoid system by preventing the metabolism of endocannabinoids through fatty acid amide hydrolase inhibition while also inhibiting transient receptor potential vanilloid Type 1 channels. Effects of AA-5-HT were compared with the direct cannabinoid receptor Type 1 agonist arachidonoyl-2'-chloroethylamide (ACEA). In Experiment 1, mice were pretreated with seven daily injections of AA-5-HT, ACEA, or vehicle prior to assessments of locomotor activity using open field (OF) testing and phasic dopamine release using in vivo fixed potential amperometry. Chronic exposure to AA-5-HT did not alter locomotor activity or mesolimbic dopamine functioning. Chronic exposure to ACEA decreased rearing and decreased phasic dopamine release while increasing the dopaminergic response to cocaine. In Experiment 2, mice underwent AA-5-HT, ACEA, or vehicle conditioned place preference, then saccharin preference testing, a measure commonly associated with anhedonia. Mice did not develop a conditioned place preference or aversion for AA-5-HT or ACEA, and repeated exposure to AA-5-HT or ACEA did not alter saccharin preference. Altogether, the findings suggest that neither of these drugs induce behaviors that are classically associated with abuse liability in mice; however, direct cannabinoid receptor Type 1 agonism may play more of a role in mediating mesolimbic dopamine functioning than indirect cannabinoid agonism. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
- 1 April 2024
- Published by American Psychological Association (APA) in Behavioral Neuroscience
- Vol. 138 (2) , 108-124
Indirect and direct cannabinoid agonists differentially affect mesolimbic dopamine release and related behaviors.
The cannabinoid system is being researched as a potential pharmaceutical target for a multitude of disorders. The present study examined the effect of indirect and direct cannabinoid agonists on mesolimbic dopamine release and related behaviors in C57BL/6J (B6) mice. The indirect cannabinoid agonist N-arachidonoyl serotonin (AA-5-HT) indirectly agonizes the cannabinoid system by preventing the metabolism of endocannabinoids through fatty acid amide hydrolase inhibition while also inhibiting transient receptor potential vanilloid Type 1 channels. Effects of AA-5-HT were compared with the direct cannabinoid receptor Type 1 agonist arachidonoyl-2'-chloroethylamide (ACEA). In Experiment 1, mice were pretreated with seven daily injections of AA-5-HT, ACEA, or vehicle prior to assessments of locomotor activity using open field (OF) testing and phasic dopamine release using in vivo fixed potential amperometry. Chronic exposure to AA-5-HT did not alter locomotor activity or mesolimbic dopamine functioning. Chronic exposure to ACEA decreased rearing and decreased phasic dopamine release while increasing the dopaminergic response to cocaine. In Experiment 2, mice underwent AA-5-HT, ACEA, or vehicle conditioned place preference, then saccharin preference testing, a measure commonly associated with anhedonia. Mice did not develop a conditioned place preference or aversion for AA-5-HT or ACEA, and repeated exposure to AA-5-HT or ACEA did not alter saccharin preference. Altogether, the findings suggest that neither of these drugs induce behaviors that are classically associated with abuse liability in mice; however, direct cannabinoid receptor Type 1 agonism may play more of a role in mediating mesolimbic dopamine functioning than indirect cannabinoid agonism. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
- Open Access
- 23 December 2023
- Published by MDPI AG in Brain Sciences
- Vol. 14 (1) , 20
A Special Issue on the Roles of Dopamine in Neural Circuits, Genetics, and Behavior
Over the past 80 years, research on dopamine has undergone significant evolution, reshaping our understanding of its roles in the brain and the body
- 23 December 2023
- Published by MDPI AG in Brain Sciences
- Vol. 14 (1) , 20
Open AccessA Special Issue on the Roles of Dopamine in Neural Circuits, Genetics, and Behavior
Over the past 80 years, research on dopamine has undergone significant evolution, reshaping our understanding of its roles in the brain and the body
- 3 September 2022
- Published by Springer Nature in Experimental Brain Research
- Vol. 240 (10) , 2803-2815
Age-dependent effects of social isolation on mesolimbic dopamine release
In humans, social isolation is a known risk factor for disorders such as substance use disorder and depression. In rodents, social isolation is a commonly used environmental manipulation that increases the occurrence of behaviors related to these disorders. Age is thought to influence the effects of social isolation, but this predictive relationship is not well-understood. The present study aimed to determine the effects of social isolation on mesolimbic dopamine release at different developmental age points in mice. The experimental ages and their corresponding comparison to human age stages are as follows: 1 month = adolescence, 4 months = mature adulthood, 12 months = middle adulthood, and 18 months = older adult. Mice were socially isolated for 6 weeks during these developmental stages, then in vivo fixed potential amperometry with recording electrodes in the nucleus accumbens was used to measure stimulation-evoked dopamine release, the synaptic half-life of dopamine, dopamine autoreceptor functioning, and the dopaminergic response to cocaine. Isolation altered dopamine functioning in an age-dependent manner. Specifically, isolation increased dopamine release in the adult ages, but not adolescence, potentially due to increased inhibitory effects of dopamine autoreceptors following adolescent social isolation. Regarding the cocaine challenge, isolation increased dopaminergic responses to cocaine in adolescent mice, but not the adult mice. These findings have implications for clinical and experimental settings. Elucidating the relationship between age, social isolation, and neurochemical changes associated with substance use disorder and depression may lead to improvements in preventing and treating these disorders.
- 3 September 2022
- Published by Springer Nature in Experimental Brain Research
- Vol. 240 (10) , 2803-2815
Age-dependent effects of social isolation on mesolimbic dopamine release
In humans, social isolation is a known risk factor for disorders such as substance use disorder and depression. In rodents, social isolation is a commonly used environmental manipulation that increases the occurrence of behaviors related to these disorders. Age is thought to influence the effects of social isolation, but this predictive relationship is not well-understood. The present study aimed to determine the effects of social isolation on mesolimbic dopamine release at different developmental age points in mice. The experimental ages and their corresponding comparison to human age stages are as follows: 1 month = adolescence, 4 months = mature adulthood, 12 months = middle adulthood, and 18 months = older adult. Mice were socially isolated for 6 weeks during these developmental stages, then in vivo fixed potential amperometry with recording electrodes in the nucleus accumbens was used to measure stimulation-evoked dopamine release, the synaptic half-life of dopamine, dopamine autoreceptor functioning, and the dopaminergic response to cocaine. Isolation altered dopamine functioning in an age-dependent manner. Specifically, isolation increased dopamine release in the adult ages, but not adolescence, potentially due to increased inhibitory effects of dopamine autoreceptors following adolescent social isolation. Regarding the cocaine challenge, isolation increased dopaminergic responses to cocaine in adolescent mice, but not the adult mice. These findings have implications for clinical and experimental settings. Elucidating the relationship between age, social isolation, and neurochemical changes associated with substance use disorder and depression may lead to improvements in preventing and treating these disorders.
- 1 June 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 756, 135952
A high fat western diet attenuates phasic dopamine release
- 1 June 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 756, 135952
A high fat western diet attenuates phasic dopamine release
- Open Access
Indirect and Direct Cannabinoid Agonists Differentially Affect Mesolimbic Dopamine Release and Related Behaviors
The cannabinoid system is being researched as a potential pharmaceutical target for a multitude of disorders. The present study examined the effect of indirect and direct cannabinoid agonists on mesolimbic dopamine release and related behaviors in C57BL/6J (B6) mice. The indirect cannabinoid agonist N -arachidonoyl serotonin (AA-5-HT) indirectly agonizes the cannabinoid system by preventing the metabolism of endocannabinoids through fatty acid amide hydrolase (FAAH) inhibition while also inhibiting transient receptor potential vanilloid type 1 (TRPV1) channels. Effects of AA-5-HT were compared with the direct cannabinoid receptor type 1 (CB1R) agonist arachidonoyl-2’-chloroethylamide (ACEA). In Experiment 1, mice were pretreated with 7 daily injections of AA-5-HT, ACEA, or vehicle prior to assessments of locomotor activity using open field (OF) testing and phasic dopamine release using in vivo fixed potential amperometry. Chronic exposure to AA-5-HT did not alter locomotor activity or mesolimbic dopamine functioning. Chronic exposure to ACEA did not alter locomotor activity but did decrease phasic dopamine release while increasing the dopaminergic response to cocaine. In Experiment 2, mice underwent AA-5-HT, ACEA, or vehicle conditioned place preference (CPP) then saccharin preference testing, a measure commonly associated with anhedonia. Mice did not develop a CPP or aversion for AA-5-HT or ACEA, and repeated exposure to AA-5-HT or ACEA did not alter saccharin preference. Altogether, the findings suggest that neither of these drugs induce behaviors that are classically associated with abuse liability in mice; however, direct CB 1 R agonism may play more of a role in mediating mesolimbic dopamine functioning than indirect cannabinoid agonism.
Open AccessIndirect and Direct Cannabinoid Agonists Differentially Affect Mesolimbic Dopamine Release and Related Behaviors
The cannabinoid system is being researched as a potential pharmaceutical target for a multitude of disorders. The present study examined the effect of indirect and direct cannabinoid agonists on mesolimbic dopamine release and related behaviors in C57BL/6J (B6) mice. The indirect cannabinoid agonist N -arachidonoyl serotonin (AA-5-HT) indirectly agonizes the cannabinoid system by preventing the metabolism of endocannabinoids through fatty acid amide hydrolase (FAAH) inhibition while also inhibiting transient receptor potential vanilloid type 1 (TRPV1) channels. Effects of AA-5-HT were compared with the direct cannabinoid receptor type 1 (CB1R) agonist arachidonoyl-2’-chloroethylamide (ACEA). In Experiment 1, mice were pretreated with 7 daily injections of AA-5-HT, ACEA, or vehicle prior to assessments of locomotor activity using open field (OF) testing and phasic dopamine release using in vivo fixed potential amperometry. Chronic exposure to AA-5-HT did not alter locomotor activity or mesolimbic dopamine functioning. Chronic exposure to ACEA did not alter locomotor activity but did decrease phasic dopamine release while increasing the dopaminergic response to cocaine. In Experiment 2, mice underwent AA-5-HT, ACEA, or vehicle conditioned place preference (CPP) then saccharin preference testing, a measure commonly associated with anhedonia. Mice did not develop a CPP or aversion for AA-5-HT or ACEA, and repeated exposure to AA-5-HT or ACEA did not alter saccharin preference. Altogether, the findings suggest that neither of these drugs induce behaviors that are classically associated with abuse liability in mice; however, direct CB 1 R agonism may play more of a role in mediating mesolimbic dopamine functioning than indirect cannabinoid agonism.
- 1 May 2020
- Published by Elsevier in Neuroscience Letters
- Vol. 728, 133588
Deep brain stimulation enhances movement complexity during gait in individuals with Parkinson’s disease
- 1 May 2020
- Published by Elsevier in Neuroscience Letters
- Vol. 728, 133588
Deep brain stimulation enhances movement complexity during gait in individuals with Parkinson’s disease